Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer

Detalles Bibliográficos
Autores principales: Maltoni, Roberta, Bravaccini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Editorial Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073799/
https://www.ncbi.nlm.nih.gov/pubmed/35530936
http://dx.doi.org/10.21037/atm-21-6999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073799/
https://www.ncbi.nlm.nih.gov/pubmed/35530936
http://dx.doi.org/10.21037/atm-21-6999

Ejemplares similares